Cargando…

Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome

BACKGROUND: The dipeptidyl peptidase-4 (DPP4) enzyme is a novel adipokine potentially involved in the development of the metabolic syndrome (MetS). Previous observations demonstrated higher visceral adipose tissue (VAT) DPP4 gene expression in non-diabetic severely obese men with (MetS+) vs. without...

Descripción completa

Detalles Bibliográficos
Autores principales: Turcot, Valérie, Tchernof, André, Deshaies, Yves, Pérusse, Louis, Bélisle, Alexandre, Marceau, Picard, Hould, Frédéric-Simon, Lebel, Stéfane, Vohl, Marie-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637825/
https://www.ncbi.nlm.nih.gov/pubmed/23379505
http://dx.doi.org/10.1186/1758-5996-5-4
_version_ 1782475786586947584
author Turcot, Valérie
Tchernof, André
Deshaies, Yves
Pérusse, Louis
Bélisle, Alexandre
Marceau, Picard
Hould, Frédéric-Simon
Lebel, Stéfane
Vohl, Marie-Claude
author_facet Turcot, Valérie
Tchernof, André
Deshaies, Yves
Pérusse, Louis
Bélisle, Alexandre
Marceau, Picard
Hould, Frédéric-Simon
Lebel, Stéfane
Vohl, Marie-Claude
author_sort Turcot, Valérie
collection PubMed
description BACKGROUND: The dipeptidyl peptidase-4 (DPP4) enzyme is a novel adipokine potentially involved in the development of the metabolic syndrome (MetS). Previous observations demonstrated higher visceral adipose tissue (VAT) DPP4 gene expression in non-diabetic severely obese men with (MetS+) vs. without (MetS−) MetS. DPP4 mRNA abundance in VAT correlated also with CpG site methylation levels (%Meth) localized within and near its exon 2 (CpG(94) to CpG(102)) in non-diabetic severely obese women, regardless of their MetS status. The actual study tested whether DPP4 %Meth levels in VAT are different between MetS− and MetS+ non-diabetic severely obese subjects, whether variable metabolic and plasma lipid profiles are observed between DPP4 %Meth quartiles, and whether correlation exists in DPP4 %Meth levels between VAT and white blood cells (WBCs). METHODS: DNA was extracted from the VAT of 26 men (MetS−: n=12, MetS+: n=14) and 79 women (MetS−: n=60; MetS+: n=19), as well as from WBCs in a sub-sample of 17 women (MetS−: n=9; MetS+: n=8). The %Meth levels of CpG(94) to CpG(102) were assessed by pyrosequencing of sodium bisulfite-treated DNA. ANOVA analyses were used to compare the %Meth of CpGs between MetS− and MetS+ groups, and to compare the metabolic phenotype and plasma lipid levels between methylation quartiles. Pearson correlation coefficient analyses were computed to test the relationship between VAT and WBCs CpG(94-102) %Meth levels. RESULTS: No difference was observed in CpG(94-102 )%Meth levels between MetS− and MetS+ subjects in VAT (P=0.67), but individuals categorized into CpG(94-102) %Meth quartiles had variable plasma total-cholesterol concentrations (P=0.04). The %Meth levels of four CpGs in VAT were significantly correlated with those observed in WBCs (r=0.55−0.59, P≤0.03). CONCLUSIONS: This study demonstrated that %Meth of CpGs localized within and near the exon 2 of the DPP4 gene in VAT are not associated with MetS status. The actual study also revealed an association between the %Meth of this locus with plasma total-cholesterol in severe obesity, which suggests a link between the DPP4 gene and plasma lipid levels.
format Online
Article
Text
id pubmed-3637825
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36378252013-04-28 Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome Turcot, Valérie Tchernof, André Deshaies, Yves Pérusse, Louis Bélisle, Alexandre Marceau, Picard Hould, Frédéric-Simon Lebel, Stéfane Vohl, Marie-Claude Diabetol Metab Syndr Research BACKGROUND: The dipeptidyl peptidase-4 (DPP4) enzyme is a novel adipokine potentially involved in the development of the metabolic syndrome (MetS). Previous observations demonstrated higher visceral adipose tissue (VAT) DPP4 gene expression in non-diabetic severely obese men with (MetS+) vs. without (MetS−) MetS. DPP4 mRNA abundance in VAT correlated also with CpG site methylation levels (%Meth) localized within and near its exon 2 (CpG(94) to CpG(102)) in non-diabetic severely obese women, regardless of their MetS status. The actual study tested whether DPP4 %Meth levels in VAT are different between MetS− and MetS+ non-diabetic severely obese subjects, whether variable metabolic and plasma lipid profiles are observed between DPP4 %Meth quartiles, and whether correlation exists in DPP4 %Meth levels between VAT and white blood cells (WBCs). METHODS: DNA was extracted from the VAT of 26 men (MetS−: n=12, MetS+: n=14) and 79 women (MetS−: n=60; MetS+: n=19), as well as from WBCs in a sub-sample of 17 women (MetS−: n=9; MetS+: n=8). The %Meth levels of CpG(94) to CpG(102) were assessed by pyrosequencing of sodium bisulfite-treated DNA. ANOVA analyses were used to compare the %Meth of CpGs between MetS− and MetS+ groups, and to compare the metabolic phenotype and plasma lipid levels between methylation quartiles. Pearson correlation coefficient analyses were computed to test the relationship between VAT and WBCs CpG(94-102) %Meth levels. RESULTS: No difference was observed in CpG(94-102 )%Meth levels between MetS− and MetS+ subjects in VAT (P=0.67), but individuals categorized into CpG(94-102) %Meth quartiles had variable plasma total-cholesterol concentrations (P=0.04). The %Meth levels of four CpGs in VAT were significantly correlated with those observed in WBCs (r=0.55−0.59, P≤0.03). CONCLUSIONS: This study demonstrated that %Meth of CpGs localized within and near the exon 2 of the DPP4 gene in VAT are not associated with MetS status. The actual study also revealed an association between the %Meth of this locus with plasma total-cholesterol in severe obesity, which suggests a link between the DPP4 gene and plasma lipid levels. BioMed Central 2013-02-04 /pmc/articles/PMC3637825/ /pubmed/23379505 http://dx.doi.org/10.1186/1758-5996-5-4 Text en Copyright © 2013 Turcot et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Turcot, Valérie
Tchernof, André
Deshaies, Yves
Pérusse, Louis
Bélisle, Alexandre
Marceau, Picard
Hould, Frédéric-Simon
Lebel, Stéfane
Vohl, Marie-Claude
Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
title Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
title_full Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
title_fullStr Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
title_full_unstemmed Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
title_short Comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
title_sort comparison of the dipeptidyl peptidase-4 gene methylation levels between severely obese subjects with and without the metabolic syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637825/
https://www.ncbi.nlm.nih.gov/pubmed/23379505
http://dx.doi.org/10.1186/1758-5996-5-4
work_keys_str_mv AT turcotvalerie comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT tchernofandre comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT deshaiesyves comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT perusselouis comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT belislealexandre comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT marceaupicard comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT houldfredericsimon comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT lebelstefane comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome
AT vohlmarieclaude comparisonofthedipeptidylpeptidase4genemethylationlevelsbetweenseverelyobesesubjectswithandwithoutthemetabolicsyndrome